Infliximab |
Infliximab Products |
| Infliximab improved psoriasis by 75% in nearly 90% of patients. (Study of 249 Patients).: An article from: Skin & Allergy News Betsy Bates International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Infliximab quells psoriatic arthritis symptoms.(Rx) : An article from: Internal Medicine News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Maintenance Doses of Infliximab can keep Crohn's in Remission. (Steroids often not needed). : An article from: Internal Medicine News Doug Brunk International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Steroid-Refractory Ulcerative Colitis resists Infliximab. (Responders reduce Steroid Dose). : An article from: Internal Medicine News Doug Brunk International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Data Suggest Infliximab Is Safe in Pregnancy.(Brief Article): An article from: Family Practice News Nicholas Mulcahy International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Behcet's syndrome may respond to infliximab. (Six Cases).: An article from: Skin & Allergy News Nancy Walsh International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Infliximab benefits lasting in plaque psoriasis: visible psoriasis was absent in 26% of patients; 47% had no significant impact on social life or activities.(Skin ... An article from: Family Practice News Nancy Walsh Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Infliximab Maker Warns Doctors of New TB Cases. (Rheumatoid Arthritis, Crohn's).(Brief Article): An article from: Family Practice News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Infliximab/MTX combo effective against early RA: major head-to-head trial: findings may alter care for early disease.(News rheumatoid arthritis): An article from: Internal Medicine News Diana Mahoney International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Remicade[R] (infliximab) studied for treating psoriatic arthritis.(New Products): An article from: Dermatology Nursing Jannetti Publications, Inc. The Gale Group Jannetti Publications, Inc. |
Sale Price: $5.95
|
| RA response much improved by combo: infliximab-methotrexate.(Clinical Rounds): An article from: Family Practice News Diana Mahoney International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Infliximab delivers in severe psoriatic arthritis.(Skin Disorders): An article from: Family Practice News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Infliximab effective for active ulcerative colitis: in two phase III trials, the drug reduced symptoms, induced remission, and led to mucosal healing.(Digestive ... An article from: Family Practice News Kathleen Louden Thomson Gale Thomson Gale |
Sale Price: $5.95
|

Not Signed In - 


